Parenteral Drug Manufacturing—CDMO Outlook: A Capacity Crunch or Easing?
By

By
What is the supply and demand outlook for fill–finish capacity in the CDMO/CMO sector? Is a capacity crunch or capacity ease in the making? And how will hot-product areas, such…

Bio/Pharma Industry Outlook, Supply Chains 2025: The Year Ahead
By

By
What will be the key issues shaping bio/pharma supply chains in 2025? Looking at the impact of potential changes in US tariff and trade policy. Plus, what lies ahead in…